Impact Stories Using AI Technology to Increase Access to Eye Care in Rural Maine January 29, 2026 Diabetic retinopathy (DR) is the leading cause of preventable blindness. The DR screening target recommended by the Centers for Medicare and Medicaid (67%) had never been reached at MaineHealth’s Western Maine Primary Care (WMPC) in Norway, Maine. How […]
Taking Care of First Responders in Wisconsin
dsdsdsdsds
Safe Pregnancies for Moms in Alabama
Study shows treating preexisting high blood pressure in pregnancy improves maternal and fetal outcomes https://www.uab.edu/news/health-medicine/study-shows-treating-preexisting-high-blood-pressure-in-pregnancy-improves-maternal-and-fetal-outcomes Visit the Journal of Clinical and Translational Science to learn how Dr. Alan Tita got involved in clinical research and how he navigated this award-winning research. More than 2 percent of pregnant women in the United States have chronic hypertension, […]
Diagnosing Rare Diseases Early in Massachusetts
Whole Genome Sequencing Doubles Diagnosis Rates for Genetic Disorders in Newborns A Comparative Analysis of Rapid Whole Genomic Sequencing and a Targeted Neonatal Gene Panel in Infants with a Suspected Genetic Disorder: The Genomic Medicine for Ill Neonates and Infants (GEMINI) Study Visit the Journal of Clinical and Translational Science to learn how Dr. Jonathan […]
Using AI to Save Lives in New York
Einstein-Montefiore CTSA-enabled Artificial Intelligence Technology Saves Lives https://pubmed.ncbi.nlm.nih.gov/30373653/ The Einstein-Montefiore Institute for Clinical and Translational Research (ICTR) has as its core mission the improvement of human health through research. In partnership with our NIH-funded CTSA together with investments from the technology sector and from the Montefiore Health System, a new artificial intelligence (AI) tool has […]
Discovering New Uses for an Asthma Drug in Maryland
RCT for Treatment of Food Allergies https://www.nejm.org/doi/full/10.1056/NEJMoa2312382 Press Release John Hopkins Institute for Clinical and Translational Research Principal Investigator: Robert A. Wood, MD This study sought to investigate if omalizumab, an injectable, FDA-approved medication for the treatment of asthma and other allergic conditions, could protect patients with multiple, severe food allergies from potentially life-threatening reactions. […]






